These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34927501)

  • 1. Prescription analysis and cost of antidepressant drugs in major depressive disorder outpatients at the tertiary care hospital of Pakistan: a prospective approach.
    Kamran S; Khan Z; Saqlain M; Nazar Z; Khan M; Ali Z; Rashid H; Shah KU; Karatas Y; Rahman NU
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):845-851. PubMed ID: 34927501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
    Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
    Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
    Alrasheed M; Hincapie AL; Guo JJ
    J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription writing pattern among the dental practitioners of a tertiary care hospital in Karachi.
    Shah R; Alam J; Minallah S; Shabbir M; Abbasi MS; Aslam K; Ahmed N; Heboyan A
    BMC Prim Care; 2024 Jul; 25(1):273. PubMed ID: 39068392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.
    Bartova L; Fugger G; Dold M; Kautzky A; Fanelli G; Zanardi R; Albani D; Weidenauer A; Rujescu D; Souery D; Mendlewicz J; Montgomery S; Zohar J; Fabbri C; Serretti A; Kasper S
    J Affect Disord; 2023 Jul; 332():105-114. PubMed ID: 36958488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries.
    Fugger G; Bartova L; Fabbri C; Fanelli G; Dold M; Swoboda MMM; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):715-727. PubMed ID: 34989830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on the rational use of medicines in four tertiary care hospitals through validated World Health Organization prescribing drugs indicators.
    Khan Z; Ahmed N; Zafar S; Ullah Khan F; Ur Rehman A; Parreiras Martins MA; Karataş Y
    Ann Ig; 2020; 32(4):368-375. PubMed ID: 32744295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
    Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
    PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic implications of preference toward reference- versus generic-brand antidepressants in primary care.
    Gultekin O; Aydin V; Bayram D; Atac O; Akici A
    Prim Health Care Res Dev; 2024 Sep; 25():e40. PubMed ID: 39301599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
    Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial use by WHO methodology at primary health care centers: a cross sectional study in Punjab, Pakistan.
    Sarwar MR; Saqib A; Iftikhar S; Sadiq T
    BMC Infect Dis; 2018 Sep; 18(1):492. PubMed ID: 30268106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital.
    Nakao M; Takeuchi T; Yano E
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):30-5. PubMed ID: 17256448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription pattern of antidepressants in five tertiary care psychiatric centres of India.
    Tripathi A; Avasthi A; Desousa A; Bhagabati D; Shah N; Kallivayalil RA; Grover S; Trivedi JK; Shinfuku N
    Indian J Med Res; 2016 Apr; 143(4):507-13. PubMed ID: 27377509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).
    Keyloun KR; Hansen RN; Hepp Z; Gillard P; Thase ME; Devine EB
    CNS Drugs; 2017 May; 31(5):421-432. PubMed ID: 28378157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder.
    Zhou ZY; Sun S; Chopra P; Zhong Y; Totev T; Signorovitch J
    J Med Econ; 2015; 18(11):919-29. PubMed ID: 26121061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care.
    Trifirò G; Tillati S; Spina E; Ferrajolo C; Alacqua M; Aguglia E; Rizzi L; Caputi AP; Cricelli C; Samani F
    Eur J Clin Pharmacol; 2013 Feb; 69(2):227-36. PubMed ID: 22706616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study.
    Dold M; Kautzky A; Bartova L; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1960-1971. PubMed ID: 27816317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.